NASDAQ:AMLN - Amylin Pharmaceuticals Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Amylin Pharmaceuticals (NASDAQ:AMLN)

Amylin Pharmaceuticals logoAmylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. It markets two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. It is also markets a diabetes treatment, BYDUREON (exenatide extended-release for injectable suspension). BYDUREON is an extended-release medication for type 2 diabetes that provides continuous glycemic control in a once-weekly dose. Amylin maintains a research and early development program focused on peptide and protein therapeutics. It has also entered into alliances and business initiatives, including its relationship with Biocon, Limited (Biocon) to develop pharmaceutical products, including AC165198, a peptide hybrid drug candidate for diabetes, which was developed from its phybrid technology platform. In August 2012, Bristol-Myers Squibb Company acquired the Company.

Receive AMLN News and Ratings via Email

Sign-up to receive the latest news and ratings for AMLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:AMLN
CUSIPN/A
Phone+1-858-5522200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Amylin Pharmaceuticals (NASDAQ:AMLN) Frequently Asked Questions

What is Amylin Pharmaceuticals' stock symbol?

Amylin Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMLN."

Has Amylin Pharmaceuticals been receiving favorable news coverage?

Press coverage about AMLN stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Amylin Pharmaceuticals earned a coverage optimism score of 0.12 on Accern's scale. They also assigned news stories about the biopharmaceutical company an impact score of 45.99 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Amylin Pharmaceuticals?

Shares of AMLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Amylin Pharmaceuticals?

Amylin Pharmaceuticals' mailing address is 9360 Towne Centre Dr Ste 110, SAN DIEGO, CA 92121-3030, United States. The biopharmaceutical company can be reached via phone at +1-858-5522200.


MarketBeat Community Rating for Amylin Pharmaceuticals (AMLN)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about Amylin Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMLN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amylin Pharmaceuticals (NASDAQ:AMLN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)

Earnings

Amylin Pharmaceuticals (NASDAQ:AMLN) Earnings History and Estimates Chart

Earnings by Quarter for Amylin Pharmaceuticals (NASDAQ:AMLN)

Amylin Pharmaceuticals (NASDAQ AMLN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2012($0.27)($0.23)ViewN/AView Earnings Details
2/6/2012($0.16)$0.09ViewN/AView Earnings Details
10/19/2011($0.13)($0.07)ViewN/AView Earnings Details
7/26/2011($0.17)($0.21)ViewN/AView Earnings Details
4/18/2011($0.23)($0.26)ViewN/AView Earnings Details
1/26/2011($0.32)($0.13)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.34)($0.31)ViewN/AView Earnings Details
7/21/2010Q2 2010($0.29)($0.28)ViewN/AView Earnings Details
4/19/2010Q1 2010($0.28)($0.27)ViewN/AView Earnings Details
1/27/2010Q4 2009($0.27)($0.32)ViewN/AView Earnings Details
10/20/2009Q3 2009($0.30)($0.19)ViewN/AView Earnings Details
7/21/2009Q2 2009($0.35)($0.36)ViewN/AView Earnings Details
4/16/2009Q1 2009($0.35)($0.34)ViewN/AView Earnings Details
1/27/2009Q4 2008($0.51)($0.36)ViewN/AView Earnings Details
10/21/2008Q3 2008($0.51)($0.46)ViewN/AView Earnings Details
7/21/2008Q2 2008($0.50)($0.47)ViewN/AView Earnings Details
4/21/2008Q1 2008($0.48)($0.51)ViewN/AView Earnings Details
1/28/2008Q4 2007($0.44)($0.57)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Amylin Pharmaceuticals (NASDAQ:AMLN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Amylin Pharmaceuticals (NASDAQ AMLN) Insider Trading and Institutional Ownership History

Insider Trading History for Amylin Pharmaceuticals (NASDAQ:AMLN)

Amylin Pharmaceuticals (NASDAQ AMLN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Amylin Pharmaceuticals (NASDAQ AMLN) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Amylin Pharmaceuticals (NASDAQ:AMLN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amylin Pharmaceuticals (NASDAQ:AMLN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amylin Pharmaceuticals (NASDAQ AMLN) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.